# Treatment of Hepatitis C in Hemophilic Patients With HIV

> **NCT00055341** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 22 (—)

## Conditions studied

- HIV Infections
- Hepatitis C
- Hemophilia

## Interventions

- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00055341
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 22 (—)
- **Last updated:** 2008-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055341, "Treatment of Hepatitis C in Hemophilic Patients With HIV". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00055341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*